Anup Kumar Trikannad Ashwini Kumar

Assistant Professor

Last publication 2025 Last refreshed 2026-05-16

faculty

COM | Internal Med Hem-Onc

2 h-index 11 pubs 8 cited

Biography and Research Information

OverviewAI-generated summary

Anup Kumar Trikannad Ashwini Kumar's research focuses on hematologic malignancies, particularly multiple myeloma and Hodgkin lymphoma. He has investigated the clinical outcomes and survival trends associated with extranodal Hodgkin lymphoma, utilizing population-based data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database. Additionally, his work includes analyzing the incidence, survival, and demographic patterns of B-cell prolymphocytic leukemia. Dr. Kumar has also explored therapeutic interventions, such as the use of Teclistamab in treating immune thrombocytopenia in patients with multiple myeloma. His research network includes collaborators from the University of Arkansas at Fayetteville and the University of Arkansas for Medical Sciences.

Metrics

  • h-index: 2
  • Publications: 11
  • Citations: 8

Selected Publications

  • Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature (2025)
    4 citations DOI OpenAlex
  • Case Report: Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma (2025)
  • Eculizumab for Hyperhemolysis in Sickle Cell Disease: Key Insights From a Challenging Case (2024)
  • Demographics and Survival Outcomes of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Retrospective Analysis of SEER Database (2024)
  • Analyzing the incidence, survival, and demographic trends of B-cell prolymphocytic leukemia (2024)

View all publications on OpenAlex →

Collaboration Network

19 Collaborators 4 Institutions 1 Country

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics